<?xml version="1.0" encoding="UTF-8"?>
<p>Two cases of the high-level HIV-1 resistance development are of particular interest. Krasnoyarsk 16.2 patient: a woman infected via HS with the disease detected in 2014 was under treatment for four years and demonstrated a high level of compliance. Evaluation of the compliance can raise doubts since HIV-1 comprises a set of mutations (M41L, L74I, V75IM, M184IV, T215NSY, Q151M, K103N, E138K, and G190S) causing high-level resistance to all NRTIs, NNRTIs except for tenofovir and etravirine to which low-level resistance was registered.</p>
